ALZAMEND NEURO, INC. Conversion of Stock, Shares Issued
ALZAMEND NEURO, INC. (ALZN) reported Conversion of Stock, Shares Issued of 3.79 million shares for the 9-month period ending 2025-01-31, per its 10-Q filed 2025-03-10.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:ConversionOfStockSharesIssued1 · last filed 2025-03-10
- ALZAMEND NEURO, INC. conversion of stock, shares issued for the quarter ending 2025-01-31 was 0.00 shares.
- ALZAMEND NEURO, INC. conversion of stock, shares issued for the quarter ending 2024-10-31 was 3.61M shares.
| Period end | Conversion of Stock, Shares Issued 3 month | Conversion of Stock, Shares Issued 6 month | Conversion of Stock, Shares Issued 9 month |
|---|---|---|---|
| 2025-01-31 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-03-10 | 3.61M shares derived: sum of 2 quarters · filed 2025-03-10 | 3.79M shares 10-Q · filed 2025-03-10 |
| 2024-10-31 | 3.61M shares 10-Q · filed 2024-12-11 | 3.79M shares 10-Q · filed 2024-12-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Medicus Pharma Ltd. (MDCX) | $0.010B |